Hilltop Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Hilltop Partners's MRK Position: Q1 2026 in Review
Hilltop Partners reduced its Merck (MRK) stake by 9% in Q1 2026, selling an estimated $129K and leaving 11,335 shares worth $1.36M. The position accounts for 0.35% of the portfolio, ranked #42.
Hilltop Partners first reported a position in MRK in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.48M in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Hilltop Partners held 11,335 shares of Merck worth $1.36M as of Q1 2026.
- Hilltop Partners sold 1,119 Merck shares in Q1 2026, an estimated $129K.
- Merck made up 0.35% of Hilltop Partners's portfolio in Q1 2026, its #42 holding.
- Hilltop Partners first reported a position in Merck in Q2 2023 and has held it in 12 quarters since.
- Hilltop Partners's Merck position peaked at $1.48M in Q2 2024.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Hilltop Partners's 13F filing for Q1 2026, filed 12 May 2026.